北京
分享至
《电鳗财经》注意到，此时减持博瑞医药的股票并非最佳时机，过去四个月该公司的股价下降超过60%，从每股65元下降至每股22元附近。该公司的股价的下降与其业绩增长放缓或许...
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
